S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
NASDAQ:QNRX

Quoin Pharmaceuticals (QNRX) Stock Price, News & Analysis

$0.95
+0.08 (+9.20%)
(As of 03/28/2024 ET)
Today's Range
$0.86
$0.97
50-Day Range
$0.84
$3.91
52-Week Range
$0.80
$12.00
Volume
160,391 shs
Average Volume
619,057 shs
Market Capitalization
$940,500.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.00

Quoin Pharmaceuticals MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
321.1% Upside
$4.00 Price Target
Short Interest
Healthy
3.40% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.44mentions of Quoin Pharmaceuticals in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.95 out of 5 stars

QNRX stock logo

About Quoin Pharmaceuticals Stock (NASDAQ:QNRX)

Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). The company is also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat NS; and QRX008 for the treatment of scleroderma. It has a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; a Master Service Agreement with Therapeutics Inc.; and a research agreement with Queensland University of Technology. The company was founded in 2018 and is based in Ashburn, Virginia.

QNRX Stock Price History

QNRX Stock News Headlines

“The Stock Market’s Bull Run is Far from Over” -Barrons
Barron's reports that the "stock market's bull run is FAR from over…" And recent economic growth will fuel the price of select stocks in the coming months!
Quoin Pharmaceuticals: Q4 Earnings Insights
“The Stock Market’s Bull Run is Far from Over” -Barrons
Barron's reports that the "stock market's bull run is FAR from over…" And recent economic growth will fuel the price of select stocks in the coming months!
QTI, RNLX and MTC among pre-market losers
Quoin Pharmaceuticals Ltd ADR
Quoin Pharmaceuticals Ltd ADR QNRX
See More Headlines
Receive QNRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Quoin Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
3/28/2024
Next Earnings (Estimated)
5/13/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:QNRX
Employees
4
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$4.00
High Stock Price Target
$4.00
Low Stock Price Target
$4.00
Potential Upside/Downside
+321.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-8,690,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$5.74 per share

Miscellaneous

Free Float
954,000
Market Cap
$940,698.00
Optionable
Not Optionable
Beta
1.88
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Dr. Michael Myers Ph.D. (Age 62)
    Co-Founder, CEO & Chairman
    Comp: $661.8k
  • Ms. Denise Carter (Age 55)
    Co-Founder, COO & Director
    Comp: $537.8k
  • Mr. Gordon Bruce Dunn J.D. (Age 60)
    Chief Financial Officer
    Comp: $523.38k

QNRX Stock Analysis - Frequently Asked Questions

Should I buy or sell Quoin Pharmaceuticals stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Quoin Pharmaceuticals in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" QNRX shares.
View QNRX analyst ratings
or view top-rated stocks.

What is Quoin Pharmaceuticals' stock price target for 2024?

1 Wall Street analysts have issued 1-year price targets for Quoin Pharmaceuticals' shares. Their QNRX share price targets range from $4.00 to $4.00. On average, they expect the company's share price to reach $4.00 in the next year. This suggests a possible upside of 321.1% from the stock's current price.
View analysts price targets for QNRX
or view top-rated stocks among Wall Street analysts.

How have QNRX shares performed in 2024?

Quoin Pharmaceuticals' stock was trading at $4.91 at the start of the year. Since then, QNRX stock has decreased by 80.7% and is now trading at $0.95.
View the best growth stocks for 2024 here
.

Are investors shorting Quoin Pharmaceuticals?

Quoin Pharmaceuticals saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 33,700 shares, an increase of 159.2% from the February 29th total of 13,000 shares. Based on an average daily volume of 580,600 shares, the days-to-cover ratio is presently 0.1 days.
View Quoin Pharmaceuticals' Short Interest
.

When is Quoin Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 13th 2024.
View our QNRX earnings forecast
.

When did Quoin Pharmaceuticals' stock split?

Quoin Pharmaceuticals's stock reverse split before market open on Monday, July 17th 2023. The 1-12 reverse split was announced on Monday, July 17th 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, July 17th 2023. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.

How do I buy shares of Quoin Pharmaceuticals?

Shares of QNRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:QNRX) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners